China’s Zero‑Covid Plan & the “Heroic” Vaccine Fight
Last week, a team of scientists from the China Centre for Disease Control and Prevention (CCDC) warned that lifting restrictions in places heart‑stuck on a “zero‑Covid” stance could add about two million deaths to the year’s tally unless vaccines jump in performance.
Why Chinese Researchers Are Raising the Volume
With the Winter Olympics wrapped up in a tight “closed‑loop” bubble, the country’s sweeping lockdowns are under fire. The study pulls data from Chile’s CoronaVac rollout and the UK’s mix of Pfizer and AstraZeneca shots to hit the math hard:
- Baseline efficacy against symptomatic disease – 68.3 %
- Baseline efficacy against death – 86 %
- Using 95 % global vaccination and 2019‑level mobility, they project 234 million infections this year – 64 million showing symptoms and 2 million deaths.
The “Do‑It‑Better” Playbook
They say the trick to get Covid down to influenza‑like numbers is a 40 % infection‑blocking vaccine with a 90 % symptom‑preventing edge. In other words: stop folks from getting sick in the first place, not just from getting the nasty cough.
“The key to controlling Covid‑19 lies in the development and widespread use of vaccines that are more effective at preventing infection,” the researchers read in their bulletin.
China’s Stubborn Stance
While places like Singapore, Australia and New Zealand have pivoted to a “living with Covid” approach, China keeps sealing off whole cities—even Baise in Guangxi. The Olympics bubble drew criticism from athletes, who called the setup “over the top.”
The CCDC’s chief epidemiologist, Wu Zunyou, told the Global Times: “We once thought vaccines could contain Covid, but now it appears comprehensive measures are the only reliable tool.”
Takeaway
In short, China’s next‑level vaccine—one that can block the virus before it even starts—might be the golden ticket to keep the country out of a fatal Covid‑fallout. For now, the lockdowns keep the lights on, but the math says there’s room for improvement.
